Today's Date:
Become a fan on Facebook Follow us on Twitter Connect with us on LinkedIn Bookmark and Share
Site Navigation:

Air Force Medical Service

Laboratory Information:

Air Force Medical Service
AFMSA/SG5M-South
2261 Hughes Ave., Ste. 158 (Bldg. 171)
Lackland AFB, TX 78236-9854
Website: http://www.afms.af.mil/
Agency/Department: Dept. of Defense - Air Force
Region: Mid-Continent

FLC Laboratory Representative:

Dr. Sirie Blankenship
Phone: (210) 395-9820
Fax: (210) 395-9864
Email: afmsa.sg5m.technologytransferoffice@us.af.mil

Sherrilynne Cherry
Phone: (210) 395-9849
Fax: (210) 395-9864
Email: afmsa.sg5m.technologytransferoffice@us.af.mil

Background/History of the Laboratory:

The U.S. Air Force Surgeon General’s mission is to develop and implement medical programs and policies for a worldwide medical enterprise for beneficiaries consisting of active duty and retired military personnel and their family members.  In addition, the Air Force Surgeon General advises the Secretary of the Air Force and Air Force Chief of Staff, as well as the Assistant Secretary of Defense for Health Affairs, on matters pertaining to the medical aspects of the air expeditionary force and the health of Air Force personnel.  Clinical research is an integral component of Air Force Medical Service (AFMS) operations.  Authority for AFMS clinical research is granted generally by 10 USC §2358.  More specifically, authority is provided through DOD Directive 6200.04, Force Health Protection, which reads, “The Department of Defense shall pursue scientific and technological advancements to improve and protect the health of the force through medical research, development, clinical investigations, technology insertion, and appropriate acquisition strategies.”

Mission of the Laboratory:

The AFMS laboratory executes a multifaceted program of phased efforts to develop knowledge and/or enhance technical sophistication of novel devices, systems, drugs, biologics and other medical products related to diagnosis, treatment, and maintenance of clinical health problems of concern to beneficiaries of military healthcare and used in aerospace expeditionary operations to preserve service members’ health and mission capabilities.  AFMS research is highly distributed encompassing AFMS researchers assigned to and conducting research at AFMS and other DOD, federal, and nonfederal healthcare, academic and research activities.  The Director of Research and Acquisitions, Air Force Medical Support Agency, Office of the Surgeon General (AFMSA/SG5), oversees research, development, acquisition, and transitioning of required capabilities into fielded medical systems. This includes research, development and acquisition requirements determination, modernization strategies, and advocating for resources to support research, development, acquisition, testing and evaluation, and operational and oversight authority of the Air Force Medical Service Office of Research and Technology Applications (AFMS ORTA) on behalf of the Air Force Surgeon General.  AFMS ORTA located at AFMSA/SG5M-South (San Antonio, Texas) serves as the focal point for clinical research technology transfer. We support translation of clinical research into practice, facilitating clinical researchers’ collaborations with industry and academia, and enabling the Air Force Surgeon General to realize benefits from research investments.  Our scope does not address aerospace medical or other nonmedical research technology transfer as other Air Force ORTAs provide this support.  The AFMS ORTA provides the collaborative environment necessary to effectively transfer research to nonfederal entities for commercialization and introduction into medical practice.  Medical technology emerging from the AFMS, in most cases, has a broader application to civilian medical practice than to military medical practice. This does not diminish the military impact of this medical technology. However, it does imply all such technologies should be carefully examined as to their domestic technology transfer potential to enhance the public benefit of defense health program expenditures on clinical research.

Facilities:

  • 60th Medical Group, David Grant Medical Center, Travis Air Force Base, California
  • 81st Medical Group, Keesler Medical Center, Keesler Air Force Base, Mississippi
  • San Antonio Military Health System, Joint Base San Antonio - Lackland, Texas
  • 88th Medical Group, Wright-Patterson Medical Center, Wright-Patterson Air Force Base, Ohio
  • 99th Medical Group, Mike O’Callaghan Federal Medical Center, Nellis Air Force Base, Nevada
  • Center for the Sustainment of Trauma & Readiness Skills – Baltimore, Maryland
  • Center for the Sustainment of Trauma & Readiness Skills – Cincinnati, Ohio
  • Center for the Sustainment of Trauma & Readiness Skills – St. Louis, Missouri
  • U.S. Air Force Academy Life Science Research Center, Colorado Springs, Colorado
  • U.S. Air Force School of Aerospace Medicine, Wright-Patterson Air Force Base, Ohio 

Technology Transfer Mechanisms:

  • Commercial Test Agreement (CTA)
  • Cooperative Research and Development Agreements (CRADAs)
  • Educational Partnership Agreements (EPAs)
  • Non-Disclosure Agreements
  • Patent License Agreements
  • Material (or Equipment) Transfer Agreements (MTAs or ETAs)
  • Invention License Agreements (ILAs)
  • Partnership Intermediary Agreements (PIAs)
  • Joint Ownership Agreements (JTOs)

Technology Areas of Expertise:

  • Human Performance
  • Enroute Care
  • Expeditionary Medicine
  • Force Health Protection
  • Health Informatics
  • Operational Medicine